20. November 2009 00:16
A team led by scientists at The Scripps Research Institute have discovered a direct link between insulin-a hormone long associated with metabolism and metabolic disorders such as diabetes-and core body temperature. While much research has been conducted on insulin since its discovery in the 1920s, this is the first time the hormone has been connected to the fundamental process of temperature regulation.
[More]
8ab6b755-b25b-4761-a40b-16eba752d9c0|0|.0
Posted in: Medical Research News | Medical Condition News
Tags: Brain, Brown Fat, Cell, Cellular Biology, Diabetes, Hypothermia, Immunology, Insulin, Metabolism, Obesity, Pfizer, Sleep, Vaccine, Weight Loss
17. November 2009 06:05
Research projects in the areas of biology and mathematics scored top marks this evening, as Marissa Suchyta of South Barrington, Illinois and the team of Randy Jia of Rochester Hills, Michigan and David Lu of Bloomfield Hills, Michigan received the highest honors at the Region Three Finals of the 2009 Siemens Competition in Math, Science & Technology, the nation's premier high school science competition.
[More]
10. November 2009 01:00
In research that sheds light on the perils of yo-yo dieting and repeated bouts of sugar-bingeing, researchers from The Scripps Research Institute have shown in animal models that cycling between periods of eating sweet and regular-tasting food can activate the brain's stress system and generate overeating, anxiety, and withdrawal-like symptoms.
[More]
16f5be62-84dc-49b0-922d-08868f69b6b5|0|.0
Posted in: Medical Condition News
Tags: Abstinence, Amygdala, Anxiety, Brain, Cellular Biology, Diabetes, Diet, Drug Abuse, Ethanol, Health and Human Services, Immunology, Stress, Vaccine, Weight Loss
2. November 2009 07:48
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (“The Liver Meeting”).
[More]
573f053d-e50f-4dea-90cd-57d36987599d|0|.0
Posted in: Medical Science News | Disease/Infection News
Tags: Biochemistry, Cardiomyopathy, Cell, Cellular Biology, Hypercholesterolemia, Life Expectancy, microRNA, Nervous System, Neuropathy, Oncology, Physiology, RNAi Therapeutics, Virus
30. October 2009 07:00
At its most benign, the autoimmune disease scleroderma can discolor parts of the skin of its sufferers. At its most pernicious, it can thicken and harden their skin, their blood vessels, and their internal organs before, in many cases, killing them.
[More]
15. October 2009 05:40
Our brains, it turns out, are eco-friendly. A study published in Science and reviewed by F1000 Biology members Venkatesh Murthy and Jakob Sorensen reveals that our brains have the amazing ability to be energy efficient.
[More]
25. September 2009 23:50
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human clinical trials, which will be a welcome event for disease sufferers who currently have few treatment options.
[More]
23. September 2009 05:10
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company’s ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company’s Cambridge, UK and Palo Alto, California locations.
[More]
17. September 2009 04:21
Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced a new study has been published identifying the mechanism of action of the anti-cancer drug GMX1778. Co-authored by scientists at Gemin X Pharmaceuticals and Metabolon, the paper “The Small Molecule GMX1778 is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in NAPRT1-Deficient Tumors” appears online ahead of print in Molecular and Cellular Biology.
[More]
14. September 2009 07:17
Carnegie Mellon University, the University of Pittsburgh and UPMC (University of Pittsburgh Medical Center) have driven a dramatic shift in the Pittsburgh economy during the last four decades, transforming the city from a manufacturing town to an international knowledge-based center for research, education and medicine.
[More]
9. September 2009 04:29
Active, but non-invasive breast cancer is set free to roam as invasive breast cancer when an overexpressed protein converts it to a different cell type, scientists at The University of Texas M. D. Anderson Cancer Center report in the Sept. 9 issue of the journal Cancer Cell.
[More]
9. September 2009 01:26
Researchers at the University of Leicester and Institute for Molecular and Cellular Biology in Portugal studied new protective properties of vitamin C in cells from the human skin, which could lead to better skin regeneration.
[More]
4. September 2009 00:20
In a biological rendition of fiction's Strange Case of Dr. Jekyll and Mr. Hyde, researchers from the Mayo Clinic campus in Florida and Harvard Medical School have found that a protein thought to protect against cancer development can actually spur the spread of tumors.
[More]
4. September 2009 00:07
A team led by scientists from The Scripps Research Institute has discovered a genetic cause of progressive hearing loss. The findings will help scientists better understand the nature of age-related decline in hearing and may lead to new therapies to prevent or treat the condition.
[More]
19f67ca4-1b31-415d-877d-4fc32bceca7f|0|.0
Posted in: Medical Science News | Medical Condition News
Tags: Brain, Cell, Cellular Biology, DNA, Genetics, Genomics, Hearing Loss, Hospital, Immunology, Stereocilia, Vaccine
28. August 2009 00:41
Cell cycle checkpoints act like molecular tripwires for damaged cells, forcing them to pause and take stock. Leave the tripwire in place for too long, though, and cancer cells will press on regardless, making them resistant to the lethal effects of certain types of chemotherapy, according to researchers at the Salk Institute for Biological Studies.
[More]
381d4d7e-172d-4579-98eb-f806d4582d23|0|.0
Posted in: Medical Science News | Disease/Infection News
Tags: Breast Cancer, Cancer, Cell, Cellular Biology, Chemotherapy, Diabetes, DNA, Gemcitabine, Genetics, Hypoxia, Irinotecan, Neuroscience, Oncology, Polio, Stress, Vaccine